Saturation biopsy involves removing 20 to 40 cores, and its value for cancer detection is being investigated as both an initial procedure and as a secondary intervention (with a focus on lateral and apical cores; also see Section 2.4) for patients with negative initial biopsy but persistent elevated serum PSA levels. The gene discussed is KLK3; the disease is cancer.